Human papillomaviruses (HPVs), which are small, double-stranded, circular DNA viruses
infecting human epithelial cells, are associated with various benign and malignant lesions of …

This review gives an overview of current screening practices for cervical cancer. In the
introduction, we will cover approaches of population screening focusing on high-risk Human …

Background Cervical carcinogenesis is mediated by the HPV-E6 and E7 oncoproteins,
considered as biomarkers usable in managing screen-positive women. Methods We …

Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening.
Its limited specificity demands using a second (triage) test to better identify women at high …

We review developments in molecular triaging options for women who test positive for high-
risk human papillomavirus (hrHPV) on self-collected samples in the context of cervical …

In the present study, the diagnostic value of high risk‑human papillomavirus (HR‑HPV)
combined with colposcopy for the detection of cervical cancer and precancerous lesions …

Overexpression of HPV‐oncoproteins E6 and E7 is necessary for HPV‐driven cervical
carcinogenesis. Hence, these oncoproteins are promising disease‐specific biomarkers. We …

Background We investigated the impact of human papillomavirus (HPV) vaccination on the
performance of cytology-based and HPV-based screening for detection of cervical …

Carcinoma precursor lesion caused by persistent infection of human papillomavirus (HPV)
types 16 and 18 is known as a principal inducer of cervical cancer. Therefore, rapid and …

Cervical cancer is a common cancer in women. HPV16 E6 oncoprotein is a reliable
biomarker for cervical cancer. Although there are other methods for detecting E6 …